Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arthroscopic debridement with or without postoperative Orthovisc for knee osteoarthritis
ACTRN12608000195358Phase 4Completed
- Sponsor
- Hacettepe University
- Start
- Jul 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of sodium hyaluronate in knee osteoarthritis (OA) (2 arms), sponsored by Hacettepe University. Primary endpoint: WOMAC pain and function subscales. Started Jul 2004; status: completed.
02
Drugs
sodium hyaluronate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ACTRN12608000195358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000195358.